Asthma Impairment and Risk Questionnaire (AIRQ)
The Asthma Impairment and Risk Questionnaire (AIRQ) is a brief tool that combines current symptoms and future exacerbation risk into a single composite asthma control score.
Indications for Use
Used for adolescents and adults to classify current asthma control by combining symptom impairment with prior exacerbation risk. Validated to predict future exacerbations over 12 months and discriminate control levels with high accuracy (AUC≈0.85) 1 [Level II evidence]; Spanish validation showed sensitivity 89% and specificity 80% for detecting uncontrolled asthma 2 [Level II evidence]. Supports treatment adjustment and shared decision‑making.
Insights & Cautions
Identifies both current impairment and future exacerbation risk, offering stronger prediction of 12‑month exacerbations than symptom‑only tools 1 [Level II evidence].
- Strengths: Validated, reliable, responsive; MID ≈2 points 2 [Level II evidence].
- Cautions: Not a standalone diagnostic tool; may overestimate control if exacerbation history is incomplete; limited pediatric generalizability (separate Peds‑AIRQ exists).